AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
F   6.19 (+4.92%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
F   6.19 (+4.92%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
F   6.19 (+4.92%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BA   173.16 (+12.95%)
AAPL   325.12 (+0.55%)
MSFT   185.36 (+0.24%)
FB   230.16 (-1.10%)
GOOGL   1,439.25 (-0.21%)
AMZN   2,478.40 (+0.24%)
NVDA   350.78 (-0.63%)
BABA   218.61 (+2.00%)
MU   48.92 (+4.49%)
GE   7.36 (+4.40%)
TSLA   882.96 (+0.16%)
AMD   52.73 (-1.51%)
T   31.51 (+1.68%)
F   6.19 (+4.92%)
DIS   122.18 (+2.89%)
NFLX   421.97 (-1.25%)
BA   173.16 (+12.95%)
Log in

OTCMKTS:QBIOQ BioMed News Headlines

$1.85
-0.04 (-2.12 %)
(As of 06/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.80
Now: $1.85
$1.91
50-Day Range
$1.72
MA: $1.97
$2.24
52-Week Range
$0.34
Now: $1.85
$3.75
Volume64,800 shs
Average Volume73,323 shs
Market Capitalization$41.62 million
P/E RatioN/A
Dividend YieldN/A
Beta2.58

Headlines

Q BioMed (OTCMKTS QBIO) News Headlines

Source:
DateHeadline
Q BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP for Relief of Metastatic Cancer Bone PainQ BioMed Inc. Announces FDA Filing for Strontium Chloride Sr89 Injection USP for Relief of Metastatic Cancer Bone Pain
www.bloomberg.com - June 2 at 7:59 AM
Q BioMed Inc.Q BioMed Inc.
www.barrons.com - May 21 at 12:24 AM
Q BioMed Launches New Website Strontium89.com and Digital Marketing Campaign for Strontium89 (Strontium Chloride Sr-89 Injection, USP) Non-opioid Treatment for Metastatic Bone PainQ BioMed Launches New Website Strontium89.com and Digital Marketing Campaign for Strontium89 (Strontium Chloride Sr-89 Injection, USP) Non-opioid Treatment for Metastatic Bone Pain
finance.yahoo.com - May 15 at 1:53 PM
Denis Corin, CEO, of Q BioMed Inc. Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.comDenis Corin, CEO, of Q BioMed Inc. Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com
finance.yahoo.com - April 30 at 4:49 PM
Q BioMed Inc. Discusses The Commercialization of Its FDA Approved Metastatic Bone Pain Drug with The Stock Day PodcastQ BioMed Inc. Discusses The Commercialization of Its FDA Approved Metastatic Bone Pain Drug with The Stock Day Podcast
finance.yahoo.com - April 27 at 9:24 AM
Q BioMed Accelerates Rapid Development Of Novel COVID-19 TherapeuticsQ BioMed Accelerates Rapid Development Of Novel COVID-19 Therapeutics
www.nasdaq.com - April 22 at 12:30 PM
Q BioMed Initiates Rapid Development of Novel COVID-19 TherapeuticsQ BioMed Initiates Rapid Development of Novel COVID-19 Therapeutics
finance.yahoo.com - April 22 at 12:30 PM
Biotechs Working Closely & Feverishly With CDC For COVID-19 Vaccine DevelopmentBiotechs Working Closely & Feverishly With CDC For COVID-19 Vaccine Development
www.marketwatch.com - April 7 at 3:45 PM
Q Biomed plans financial restructuringQ Biomed plans financial restructuring
seekingalpha.com - April 7 at 3:45 PM
Q BioMed Enters into a Financial Restructuring of Approximately $7,800,000 Consisting of $4,000,000 New Cash and a Minimum of $3,800,000 of Debt ConversionQ BioMed Enters into a Financial Restructuring of Approximately $7,800,000 Consisting of $4,000,000 New Cash and a Minimum of $3,800,000 of Debt Conversion
finance.yahoo.com - April 7 at 3:45 PM
Q BioMed Adds to Leadership Team With Global Head of Regulatory AffairsQ BioMed Adds to Leadership Team With Global Head of Regulatory Affairs
finance.yahoo.com - March 31 at 11:19 AM
Q BioMed Treats its First Patient in Commercial Setting Following Product LaunchQ BioMed Treats its First Patient in Commercial Setting Following Product Launch
www.prnewswire.com - March 12 at 8:37 AM
Q BioMed Launches Non-opioid Treatment for Metastatic Bone PainQ BioMed Launches Non-opioid Treatment for Metastatic Bone Pain
finance.yahoo.com - February 13 at 3:01 PM
Q BioMed Partner Mannin Research Developing Potential Treatment for Patients Infected with Coronavirus and Other Infectious DiseasesQ BioMed Partner Mannin Research Developing Potential Treatment for Patients Infected with Coronavirus and Other Infectious Diseases
finance.yahoo.com - February 4 at 12:28 PM
Q BioMed Provides a Shareholder Update Ahead of the Commercial Launch of its First DrugQ BioMed Provides a Shareholder Update Ahead of the Commercial Launch of its First Drug
finance.yahoo.com - January 7 at 4:58 PM
Advanced Medical Technologies Help Stem the Evergrowing Spread of AilmentsAdvanced Medical Technologies Help Stem the Evergrowing Spread of Ailments
www.marketwatch.com - November 26 at 4:42 PM
Q BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 ActivatorQ BioMed Technology Partner Mannin Research Inc. Presents Data Showing Potential Treatment to Protect the Kidney in Acute Kidney Injury Using Mannin Tie2 Activator
finance.yahoo.com - November 26 at 4:42 PM
Patients Seek Non-Opioid Options for Cancer Pain ManagementPatients Seek Non-Opioid Options for Cancer Pain Management
www.marketwatch.com - November 20 at 2:07 PM
Q BioMed Announces FDA ApprovalQ BioMed Announces FDA Approval
finance.yahoo.com - November 20 at 9:06 AM
Biotechs Target Innovative Advances in the Battle Against CancerBiotechs Target Innovative Advances in the Battle Against Cancer
www.marketwatch.com - November 5 at 12:46 PM
Patients Demand Personalized Treatments for Cancer as Death Rates SoarPatients Demand Personalized Treatments for Cancer as Death Rates Soar
www.marketwatch.com - October 3 at 4:48 PM
Q BioMed Announces Commercial Partnership With Jubilant Radiopharma for the Distribution of its Non-Opioid Cancer Palliation Drug in the United StatesQ BioMed Announces Commercial Partnership With Jubilant Radiopharma for the Distribution of its Non-Opioid Cancer Palliation Drug in the United States
finance.yahoo.com - October 3 at 4:48 PM
Q BioMed Announces Legal Settlement and Acquisition of FDA Approved Non-Opioid Metastatic Cancer Pain DrugQ BioMed Announces Legal Settlement and Acquisition of FDA Approved Non-Opioid Metastatic Cancer Pain Drug
finance.yahoo.com - October 2 at 5:02 PM
Q Biomed and Collaborator Chemveda Life Sciences Enter Agreement for Synthesis and Manufacturing of Liver Cancer ChemotherapeuticQ Biomed and Collaborator Chemveda Life Sciences Enter Agreement for Synthesis and Manufacturing of Liver Cancer Chemotherapeutic
finance.yahoo.com - September 13 at 7:58 AM
Q BioMed and Collaborator Chemveda Life Sciences Announce Potential Chemotherapeutic Breakthrough in Liver CancerQ BioMed and Collaborator Chemveda Life Sciences Announce Potential Chemotherapeutic Breakthrough in Liver Cancer
finance.yahoo.com - August 20 at 6:57 PM
Q BioMed Responds to OTC Markets Request for Clarity on Promotional ActivityQ BioMed Responds to OTC Markets Request for Clarity on Promotional Activity
finance.yahoo.com - June 24 at 5:16 PM
Q BioMed Advances QBM-001 for the Treatment of Autism Spectrum Disorder SubtypeQ BioMed Advances QBM-001 for the Treatment of Autism Spectrum Disorder Subtype
finance.yahoo.com - June 4 at 9:29 AM
Biotechnology Accelerator, Q BioMed Inc., Selects 5W Public Relations as Agency of RecordBiotechnology Accelerator, Q BioMed Inc., Selects 5W Public Relations as Agency of Record
finance.yahoo.com - May 30 at 5:50 PM
Q BioMed IncQ BioMed Inc
www.bloomberg.com - April 27 at 4:55 PM
QBioMed Research Partner Mannin Research to Attend ARVO 2019 Annual MeetingQBioMed Research Partner Mannin Research to Attend ARVO 2019 Annual Meeting
finance.yahoo.com - April 24 at 9:25 AM
In a Major Breakthrough, Q BioMed Discovers First Biomarkers for Pediatric Nonverbal Autism SubgroupIn a Major Breakthrough, Q BioMed Discovers First Biomarkers for Pediatric Nonverbal Autism Subgroup
finance.yahoo.com - April 10 at 11:07 AM
Biotechnology Accelerator Positions Multiple Shots on Goal in the Multi-Billion Dollar Glaucoma Market with Commercialization Target in the Near TermBiotechnology Accelerator Positions Multiple Shots on Goal in the Multi-Billion Dollar Glaucoma Market with Commercialization Target in the Near Term
finance.yahoo.com - March 27 at 9:44 AM
Q BioMeds Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma SufferersQ BioMed's Industry-Changing Diagnostic Kit To Serve Unmet Need for 70 Million Glaucoma Sufferers
finance.yahoo.com - March 21 at 8:56 AM
Q Biomed to launch diagnostic kit for glaucomaQ Biomed to launch diagnostic kit for glaucoma
seekingalpha.com - March 20 at 9:11 AM
Q BioMeds Diagnostic Kit Designed to Serve Unmet Need for 70 Million Glaucoma SufferersQ BioMed's Diagnostic Kit Designed to Serve Unmet Need for 70 Million Glaucoma Sufferers
www.prnewswire.com - March 20 at 7:54 AM
Q Biomed collaborates with McMaster University to develop GDF15 biomarker glaucoma diagnostic kitQ Biomed collaborates with McMaster University to develop GDF15 biomarker glaucoma diagnostic kit
seekingalpha.com - March 19 at 9:43 AM
Q BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster UniversityQ BioMed and Mannin Research to Develop GDF15 Biomarker Glaucoma Diagnostic Kit Through Collaboration with McMaster University
finance.yahoo.com - March 19 at 9:43 AM
Q Biomeds Set to Transform Multi-Billion Dollar Glaucoma MarketQ Biomed's Set to Transform Multi-Billion Dollar Glaucoma Market
finance.yahoo.com - March 12 at 10:26 AM
Q Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington UniversityQ Biomed Licenses Novel Biomarker for Monitoring Glaucoma Severity and Progression From Washington University
finance.yahoo.com - March 11 at 11:07 AM
Numerous Upcoming Catalysts Should Drive Demand for Q BioMed’s Low-Float SharesNumerous Upcoming Catalysts Should Drive Demand for Q BioMed’s Low-Float Shares
finance.yahoo.com - March 7 at 9:53 AM
Q BioMeds Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Biotech NewspaperQ BioMed's Autism Spectrum Disorder Drug Development Program Featured in February Issue of Leading Pharma/Biotech Newspaper
finance.yahoo.com - February 26 at 9:49 AM
Interviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin Research - GlobeNewswireInterviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin Research - GlobeNewswire
globenewswire.com - February 22 at 6:10 PM
Interviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin ResearchInterviews with CEO Denis Corin of Q BioMed and CEO George Nikopoulos of Mannin Research
finance.yahoo.com - February 22 at 10:16 AM
Demand for New Glaucoma Therapies Has Greatest Potential to Drive Value for Q BioMeds ShareholdersDemand for New Glaucoma Therapies Has Greatest Potential to Drive Value for Q BioMed's Shareholders
finance.yahoo.com - February 8 at 9:28 AM
Q BioMed Responds to OTC Markets Request for Clarity on Investor Awareness ActivityQ BioMed Responds to OTC Markets Request for Clarity on Investor Awareness Activity
finance.yahoo.com - February 7 at 5:46 PM
Biotech Companies Introduce New Treatments as Concern Over Cancer RisesBiotech Companies Introduce New Treatments as Concern Over Cancer Rises
www.marketwatch.com - February 7 at 9:24 AM
Q BioMed to Present at 2019 BIO CEO & Investor ConferenceQ BioMed to Present at 2019 BIO CEO & Investor Conference
finance.yahoo.com - February 1 at 5:43 PM
Q BioMed to Present at 2019 BIO CEO & Investor ConferenceQ BioMed to Present at 2019 BIO CEO & Investor Conference
www.prnewswire.com - February 1 at 10:38 AM
Q BioMed Seeks Multi-billion Dollar Opportunity with New Glaucoma Treatment CandidateQ BioMed Seeks Multi-billion Dollar Opportunity with New Glaucoma Treatment Candidate
finance.yahoo.com - January 28 at 9:24 AM
Imminent FDA Decision Prompts the Ignition of Q BioMeds SharesImminent FDA Decision Prompts the Ignition of Q BioMed's Shares
finance.yahoo.com - January 18 at 7:25 PM
This page was last updated on 6/3/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.